J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,043	1,151	882.15	769.34	565.44	286.86
Short-Term Investments	4,898	178.92	67.7	0.85	1.06	-
Trading Asset Securities	-	3,171	3,647	1,922	-	6,650
Cash & Short-Term Investments	5,942	4,501	4,596	2,692	566.5	6,937
Cash Growth	42.53%	-2.08%	70.74%	375.20%	-91.83%	91.19%
Accounts Receivable	9,377	8,154	6,869	5,758	5,557	3,890
Other Receivables	-	95.76	160.06	275.92	411.27	290.23
Receivables	9,383	8,255	7,036	6,048	5,981	4,185
Inventory	5,766	5,290	5,025	4,305	4,100	3,474
Prepaid Expenses	-	190.14	163.23	167.05	120.4	122.56
Other Current Assets	4,461	991.77	1,713	2,069	1,764	807.15
Total Current Assets	25,551	19,227	18,533	15,280	12,532	15,526
Property, Plant & Equipment	6,787	6,566	6,349	5,764	5,668	5,697
Long-Term Investments	295.6	2,784	285.13	137.84	127.22	129.09
Goodwill	574.6	574.59	574.59	574.59	574.59	574.59
Other Intangible Assets	12,731	13,171	13,885	13,223	6,714	321.05
Long-Term Deferred Tax Assets	75.5	84.19	58.78	65.1	64.31	69.43
Other Long-Term Assets	1,106	326.35	250.14	486.97	386.74	58.93
Total Assets	47,124	42,738	39,941	35,539	26,074	22,381
Accounts Payable	4,097	4,107	3,563	2,386	2,245	1,869
Accrued Expenses	-	202.33	167.83	176.15	247.43	241.37
Short-Term Debt	73.2	138.04	153.43	280.18	263.15	326.45
Current Portion of Long-Term Debt	-	-	3,182	1,370	-	-
Current Portion of Leases	119.1	77.33	108.77	88.87	76.26	72.02
Current Income Taxes Payable	242.5	82.3	117.62	49.54	60.95	79.02
Current Unearned Revenue	-	10.84	12.19	11.83	17.06	16.6
Other Current Liabilities	2,210	1,705	1,378	1,181	927.51	848.05
Total Current Liabilities	6,742	6,323	8,682	5,544	3,837	3,453
Long-Term Debt	-	-	236.39	3,832	-	-
Long-Term Leases	216.8	63.53	96.38	153.21	206.18	51.41
Long-Term Unearned Revenue	15.4	19.01	16.99	24.93	31.66	49.32
Pension & Post-Retirement Benefits	-	3.39	0.62	6.01	5.12	13.62
Long-Term Deferred Tax Liabilities	1,833	1,773	1,492	1,028	475.59	567.67
Other Long-Term Liabilities	259.9	221.9	183.26	146.1	132.19	112.09
Total Liabilities	9,067	8,405	10,708	10,735	4,688	4,247
Common Stock	156.6	155.68	155.2	154.76	154.56	154.56
Additional Paid-In Capital	-	1,641	1,134	697.02	507.68	507.68
Retained Earnings	-	30,857	26,676	22,757	19,933	17,354
Comprehensive Income & Other	37,901	1,679	1,268	1,195	745.66	80.81
Total Common Equity	38,057	34,333	29,233	24,804	21,341	18,097
Minority Interest	-	-	-	-	44.9	37.05
Shareholders' Equity	38,057	34,333	29,233	24,804	21,386	18,134
Total Liabilities & Equity	47,124	42,738	39,941	35,539	26,074	22,381
Total Debt	409.1	278.9	3,777	5,724	545.59	449.88
Net Cash (Debt)	5,532	4,222	819.79	-3,032	20.92	6,487
Net Cash Growth	74.72%	415.01%	-	-	-99.68%	98.28%
Net Cash Per Share	34.88	26.61	5.17	-19.36	0.14	41.97
Filing Date Shares Outstanding	156.37	155.68	155.19	154.76	154.56	154.56
Total Common Shares Outstanding	156.37	155.68	155.19	154.76	154.56	154.56
Working Capital	18,810	12,904	9,851	9,736	8,694	12,073
Book Value Per Share	243.38	220.54	188.37	160.28	138.07	117.09
Tangible Book Value	24,752	20,587	14,774	11,006	14,053	17,202
Tangible Book Value Per Share	158.29	132.24	95.20	71.12	90.92	111.29
Land	-	329.41	329.41	5.72	5.72	5.72
Buildings	-	3,234	3,111	2,925	2,833	2,696
Machinery	-	9,697	8,767	8,363	8,095	7,800
Construction In Progress	-	467	633.22	444.09	139.06	255.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.